Constipation Treatment Latest Trend, Region, Application, End-use Industry, Growth Opportunity, Key Players, 2024-2033

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033

The Business Research Company presents an extensive market research report on the Constipation Treatment Global Market Report 2024, furnishing businesses with a competitive edge through a detailed examination of the market structure, encompassing estimates for various segments and sub-segments.

Furthermore, the report highlights on emerging trends, significant drivers, challenges, and opportunities, providing all necessary data for thriving in the industry. This report market research offers a comprehensive perspective, including an in-depth analysis of the present and future scenarios within the industry.

Market Sizing:

The constipation treatment market size has grown strongly in recent years. It will grow from $10.95 billion in 2023 to $11.65 billion in 2024 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to rising prevalence of digestive disorders, demographic changes, lifestyle factors, limited treatment options, increasing awareness of health issues.

The constipation treatment market size is expected to see strong growth in the next few years. It will grow to $15.09 billion in 2028 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to rising healthcare expenditure, increased focus on preventive healthcare, focus on pediatric constipation, growing demand for personalized healthcare solutions, rise of telemedicine, expansion of e-commerce, focus on functional foods and probiotics. Major trends in the forecast period include technological advancements in healthcare, artificial intelligence and machine learning in healthcare, focus on sustainability and eco-friendly products, collaboration between healthcare providers and technology companies, increased investment in r&d by pharmaceutical companies.

Request for free sample report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=12134&type=smp

Key Market Players:

Major companies operating in the constipation treatment market report are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bayer AG, Novartis AG, Merck & Co. Inc., Sanofi S.A., AstraZeneca plc, Fresenius Kabi AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Ltd., Boehringer Ingelheim International GmbH, Regeneron Pharmaceuticals, Bausch Health Companies Inc., Eisai Co. Ltd., Shionogi & Co. Ltd., Mallinckrodt Plc, Salix Pharmaceuticals Inc., Prestige Consumer Healthcare Inc., Taiho Pharmaceutical Co. Ltd., Ironwood Pharmaceuticals Inc., Cosmo Pharmaceuticals NV, Ferring Pharmaceuticals, RedHill Biopharma Ltd., Probi AB, 4D Pharma plc

Market Drivers:

Growing consumption of fast food is expected to propel the growth of the constipation treatment market going forward. Fast food refers to hot food that a customer cooks or orders from a specific sort of restaurant and is provided shortly. Fast foods are low in fiber and high in fat and salt, so they can lead to constipation. For instance, in August 2023, according to a report published by Budget Branders, a US-based provider of paper and plastic products, the fast food business is projected to have a global market worth 931. 7 billion dollars by 2027. Additionally, there are over 200,000 distinct fast-food outlets in the US. American consumers spend 200 billion dollars on fast food annually. Therefore, the growing consumption of fast food is driving the growth of the constipation treatment market.

Learn More About The Market Report -
https://www.thebusinessresearchcompany.com/report/constipation-treatment-global-market-report

The constipation treatment market covered in this report is segmented -

1) By Therapeutic Types: Laxatives, Chloride Channel Activators, Peripherally Acting Mu-Opioid Receptor Antagonists, GC-C (Guanylate Cyclase-C) Agonists, Other Therapeutics
2) By Disease Type: Chronic Idiopathic Constipation (CIC), Irritable Bowel Syndrome With Constipation (IBS-C), Opioid-Induced Constipation (OIC)
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

The report answers the following questions:
What are the primary factors propelling the market during the projected period?

In which region is the most substantial growth expected?

Which trend will take center stage in the upcoming period?

Want To Know More About The Business Research Company?

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.